Search Results - "tyrosine kinase"

Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients by Liu J, Mu Z, Liu L, Li K, Jiang R, Chen P, Zhou Q, Jin M, Ma Y, Xie Y, Xiang J, Li B, Ma Y, Mao X, Zhang L, Zhang T, Wu D

Connect to this object online.

From Anti-HER-2 to Anti-HER-2-CAR-T Cells: An Evolutionary Immunotherapy Approach for Gastric Cancer by Sun J, Li X, Chen P, Gao Y

Connect to this object online.

Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease by Marta Maggisano, Lucrezia Mondini, Maria Chernovsky, Paola Confalonieri, Francesco Salton, Nicolò Reccardini, Metka Kodric, Pietro Geri, Marco Confalonieri, Michael Hughes, Rossella Cifaldi, Barbara Ruaro

Connect to this object online.

The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions by Karam Khaddour, Tanner M. Johanns, George Ansstas

Connect to this object online.

Functional Involvement of TANK-Binding Kinase 1 in the MyD88-Dependent NF-κB Pathway Through Syk by Han Gyung Kim, Ji Hye Kim, Tao Yu, Jae Youl Cho

Connect to this object online.

Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment by Sahar Eljack, Stephanie David, Igor Chourpa, Areeg Faggad, Emilie Allard-Vannier

Connect to this object online.

The Activation of PDGFRβ on Mononuclear Stromal/Tumor Cells in Giant Cell Tumor of Bone After Denosumab Treatment. An Immunohistochemical Study of Five Cases by Imre Antal, Zsuzsanna Pápai, Miklós Szendrői, Tamás Perlaky, Katalin Dezső, Zoltán Lippai, Zoltán Sápi

Connect to this object online.

Extracellular polysaccharides produced by <it>Ganoderma formosanum</it> stimulate macrophage activation via multiple pattern-recognition receptors by Wang Cheng-Li, Lu Chiu-Ying, Pi Chia-Chen, Zhuang Yu-Jing, Chu Ching-Liang, Liu Wen-Hsiung, Chen Chun-Jen

Connect to this object online.

Investigations of nitazoxanide molecular targets and pathways for the treatment of hepatocellular carcinoma using network pharmacology and molecular docking by Shakeel Ahmad Khan, Terence Kin Wah Lee, Terence Kin Wah Lee

Connect to this object online.

Peripheral injury of pelvic visceral sensory nerves alters GFRa (GDNF family receptor alpha) localization in sensory and autonomic pathways of the sacral spinal cord by Shelley Lynne Forrest, Sophie Clementine Payne, Janet R Keast, Janet R Keast, Peregrine B Osborne, Peregrine B Osborne

Connect to this object online.

Impact of Dose Reduction of Afatinib Used in Patients With Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis by Ziyu Wang, Ziyu Wang, Xin Du, Xin Du, Ken Chen, Shanshan Li, Zhiheng Yu, Zhiheng Yu, Ziyang Wu, Li Yang, Dingding Chen, Wei Liu

Connect to this object online.

HIF-PH Encoded by <i>EGLN1</i> Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia by Wancheng Guo, Daomiao Liang, Peilong Wang, Le Yin, Huifang Zhang, Cheng Xing, Zineng Huang, Yinghua Wu, Heng Li, Zhao Cheng, Xiaojuan Xiao, Jing Liu, Zhihua Wang, Hongling Peng

Connect to this object online.

A physiologically‐based pharmacokinetic precision dosing approach to manage dasatinib drug-drug interactions by Christina Kovar, Helena Leonie Hanae Loer, Simeon Rüdesheim, Laura Maria Fuhr, Fatima Zahra Marok, Dominik Selzer, Matthias Schwab, Thorsten Lehr

Connect to this object online.

A validated UPLCâMS/MS method for simultaneous determination of imatinib, dasatinib and nilotinib in human plasma by Jing Zeng, Hua lin Cai, Zhi ping Jiang, Qing Wang, Yan Zhu, Ping Xu, Xie lan Zhao

Connect to this object online.

Enhancing Outcomes in Chronic Fibrotic Interstitial Lung Disease Through Aggressive Management of Nintedanib-Induced Adverse Drug Reactions: A Retrospective Analysis by Yu-Wen Chang, Meng-Yun Tsai, Yu-Ping Chang, Chien-Chang Liao, Yu-Ting Lin, Chien-Hao Lai, Meng-Chih Lin, Kuo-Tung Huang

Connect to this object online.

A ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells by Amineh Ghaderi, Wen Zhong, Mohammad Ali Okhovat, Johanna Aschan, Ann Svensson, Birgitta Sander, Johan Schultz, Thomas Olin, Anders Österborg, Mohammad Hojjat-Farsangi, Håkan Mellstedt

Connect to this object online.

A disproportionality analysis for assessing the safety of FLT3 inhibitors using the FDA Adverse Event Reporting System (FAERS) by Jie Zhou, Jinping Zhang, Qiaoyun Wang, Miaoxin Peng, Yun Qian, Fang Wu, Qi Rao, Laji DanZhen, Yonggong Yang, Siliang Wang, Mengying Liu

Connect to this object online.

Neratinib for HER2-positive breast cancer with an overlooked option by Liting Guo, Weiwei Shao, Chenfei Zhou, Hui Yang, Liu Yang, Qu Cai, Junqing Wang, Yan Shi, Lei Huang, Jun Zhang

Connect to this object online.

Synthesis and evaluation of a rociletinib analog as prospective imaging double mutation L858R/T790M in non-small cell lung cancer by Muammar Fawwaz, Kenji Mishiro, Bambang Purwono, Ryuichi Nishii, Kazuma Ogawa

Connect to this object online.

A real-world disproportionality analysis of Tivozanib data mining of the public version of FDA adverse event reporting system by Kaixuan Wang, Mengmeng Wang, Wensheng Li, Xiaohui Wang

Connect to this object online.